Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 74501-74550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05765214
Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes
NAActive, not recruiting
120 participants
Started: May 1, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05596630
Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC
NARecruiting
40 participants
Started: May 1, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05675098
Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy
EARLY_PHASE1Not yet recruiting
30 participants
Started: May 1, 2023 · Completed: Feb 1, 2027
2 conditions1 sponsor1 location
NCT06380790
Effect of Laser-aided Csf on the Rate of Leveling and Alignment of Mandibular Anterior Crowding
NARecruiting
26 participants
Started: May 1, 2023 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05593354
MicroPulse TLT - UK Study
N/ANot yet recruiting
250 participants
Started: May 1, 2023 · Completed: Dec 31, 2025
8 conditions2 sponsors0 locations
NCT06086470
Evaluating the Use of the Qidni/D Hemodialysis System by Subjects With End-Stage Renal Disease
NARecruiting
30 participants
Started: May 1, 2023 · Completed: Jul 14, 2024
1 condition1 sponsor1 location
NCT07018427
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
N/AActive, not recruiting
70 participants
Started: May 1, 2023 · Completed: Sep 1, 2025
4 conditions1 sponsor1 location
NCT06100471
Evaluation of Genetic Signature in Endometriosis Disease by Non Invasive Sampling
N/AEnrolling by invitation
150 participants
Started: May 1, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05832203
Evaluation of Planetary Health Diet Recommendation Using Mobile Application in Adults
NAActive, not recruiting
180 participants
Started: May 1, 2023 · Completed: Nov 30, 2025
4 conditions1 sponsor1 location
NCT05813210
Myocardial Ischemia Detection With a Combined Cardiovascular Magnetic Resonance and Biomarker Protocol
NANot yet recruiting
772 participants
Started: May 1, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT06070519
A Dynamic Evaluation of Chronic Heart Failure Prognosis: the MECKI Score
NARecruiting
400 participants
Started: May 1, 2023 · Completed: May 1, 2026
1 condition4 sponsors4 locations
NCT05329662
Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female
PHASE2Recruiting
130 participants
Started: May 1, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06261645
Rotofunc - Non-traumatic Shoulder Instability and Total Rotator Cuff Function
NARecruiting
100 participants
Started: May 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05724082
The Effect of Household Air Pollution on Lung Function Growth in Infants With Pneumonia in Sub-Saharan Africa
NAEnrolling by invitation
25 participants
Started: May 1, 2023 · Completed: Apr 30, 2025
6 conditions2 sponsors1 location
NCT05833893
Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
PHASE2Recruiting
10 participants
Started: May 1, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06195501
Dysphagia After Transesophageal Echocardiography in Acute Stroke - Follow Up Trial
N/ARecruiting
40 participants
Started: May 1, 2023 · Completed: Aug 31, 2025
2 conditions1 sponsor1 location
NCT05611840
RCT on Robotic vs. Endo-laparoscopic Approach for Difficult Choledocholithiasis
NARecruiting
90 participants
Started: May 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05414500
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
PHASE1Recruiting
10 participants
Started: May 1, 2023 · Completed: Jul 31, 2026
2 conditions3 sponsors1 location
NCT06198309
Risk Prediction Model for Exacerbating Phenotype in Patients With Chronic Obstructive Pulmonary Disease
N/ARecruiting
365 participants
Started: May 1, 2023 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT05820178
tDCS and rTMS in Patients With Early Disorders of Consciousness
NANot yet recruiting
120 participants
Started: May 1, 2023 · Completed: Apr 1, 2026
3 conditions1 sponsor0 locations
NCT04881682
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PHASE2Recruiting
20 participants
Started: May 1, 2023 · Completed: Mar 1, 2026
1 condition2 sponsors1 location
NCT05828888
CHIP in Endothelial Dysfunction Associated With HEpEF
N/ANot yet recruiting
80 participants
Started: May 1, 2023 · Completed: Feb 1, 2026
1 condition2 sponsors0 locations
NCT06461312
Combined PRF of the Pudendal Nerve With Ganglion Impar Block Effectively Alleviates Pudendal Neuralgia
NARecruiting
40 participants
Started: May 1, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT03734952
Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy
NARecruiting
537 participants
Started: May 1, 2023 · Completed: Jan 1, 2029
1 condition1 sponsor1 location
NCT05790473
Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
N/ARecruiting
10,000 participants
Started: May 1, 2023 · Completed: May 1, 2025
2 conditions4 sponsors1 location
NCT05782582
Chronic Coronary Syndrome in Swedish Primary Care
NARecruiting
500 participants
Started: May 1, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors3 locations
NCT06056349
Benzodiazepine Study for the Treatment of Seizure Clusters in a Third Level Mexican Neurological Center
NARecruiting
150 participants
Started: May 1, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05797961
HIV Self-testing With Online Supervision for Vietnamese MSM
NAActive, not recruiting
100 participants
Started: May 1, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05825196
Study of Serum Tumor Markers of HBV Associated HCC
N/ANot yet recruiting
164 participants
Started: May 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05840341
Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer
PHASE3Recruiting
306 participants
Started: May 1, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor4 locations
NCT05760820
SES Children (SES Mini/SES Nxt) - A Digital Intervention for Children of Divorce
NARecruiting
1,000 participants
Started: May 1, 2023 · Completed: May 1, 2026
3 conditions21 sponsors1 location
NCT06483490
Environmental Pollutants in COPD and Lung Cancer
N/ARecruiting
200 participants
Started: May 1, 2023 · Completed: May 1, 2026
1 condition2 sponsors1 location
NCT05855083
Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
PHASE2Recruiting
18 participants
Started: May 1, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor16 locations
NCT06291506
SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER).
NARecruiting
176 participants
Started: May 1, 2023 · Completed: May 1, 2026
4 conditions1 sponsor1 location
NCT04550845
Understanding of Genetics by Men At Risk for Prostate Cancer
NARecruiting
90 participants
Started: May 1, 2023 · Completed: Sep 27, 2027
1 condition2 sponsors3 locations
NCT05864872
the Best Approach for Blocking Intercostobrachial and Medial Brachial Cutaneous Nerves in the Upper Arm Surgery
NARecruiting
140 participants
Started: May 1, 2023 · Completed: Mar 1, 2024
1 condition1 sponsor1 location
NCT07002619
ChOlanGiography Performed Routinely Versus Selectively During Cholecystectomy: A NAtional Registry-based Randomized Controlled Trial
NARecruiting
6,000 participants
Started: May 1, 2023 · Completed: Dec 31, 2028
2 conditions3 sponsors1 location
NCT05680363
Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients
NARecruiting
40 participants
Started: May 1, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor4 locations
NCT05585814
CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Microsatellite Stable Locally Advanced Rectal Cancer
PHASE2Recruiting
30 participants
Started: May 1, 2023 · Completed: May 1, 2028
1 condition1 sponsor1 location
NCT07027059
Neural Mobilization Exercises on Pain and Central Sensitization
NARecruiting
30 participants
Started: May 1, 2023 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05833971
Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma
PHASE2Not yet recruiting
43 participants
Started: May 1, 2023 · Completed: Jun 1, 2026
2 conditions1 sponsor0 locations
NCT06684938
US Guided Sacroiliac Joint Injection
NARecruiting
100 participants
Started: May 1, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor2 locations
NCT05868343
Effectiveness of a Hybrid Cardiac Rehabilitation Program
NAActive, not recruiting
278 participants
Started: May 1, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor9 locations
NCT05831891
Fruquintinib and SeRplulimab: Opening New Frontiers in Treating Non-clear Cell Renal Cell Carcinoma
PHASE2Recruiting
39 participants
Started: May 1, 2023 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06097325
Impostor Syndrome and Burnout in Swiss Residents and Chief Residents Anaesthesiologists
N/AEnrolling by invitation
100 participants
Started: May 1, 2023 · Completed: Dec 31, 2024
4 conditions2 sponsors1 location
NCT05346081
Pulmonary Function Assessment and Evaluation Using Self-administrable and Portable Electrical Impedance Tomography
N/ARecruiting
125 participants
Started: May 1, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05794880
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NARecruiting
40 participants
Started: May 1, 2023 · Completed: May 31, 2032
13 conditions1 sponsor1 location
NCT05640726
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
PHASE2Not yet recruiting
30 participants
Started: May 1, 2023 · Completed: May 1, 2026
1 condition1 sponsor0 locations
NCT05880472
Percutaneous Holmium Injection in Pancreatic Cancer
NAActive, not recruiting
6 participants
Started: May 1, 2023 · Completed: Apr 22, 2025
1 condition3 sponsors1 location
NCT06122012
To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China
NARecruiting
136 participants
Started: May 1, 2023 · Completed: May 31, 2024
1 condition1 sponsor1 location